▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

HP Inc. Q4 22 Earnings Conference Call At 5:00 PM ET

By RTTNews Staff Writer ✉ | Published: 11/22/2022 6:00 AM ET

HP Inc. (HPQ) will host a conference call at 5:00 PM ET on November 22, 2022, to discuss Q4 22 earnings results.

To access the live webcast, log on to https://investor.hp.com/events/event-details/2022/Q4-2022-HP-Inc-Earnings-Conference-Call/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

U.S. Covid Metrics Signal Ease In Pandemic

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

HP Reports Q4 Results, To Cut Up To 6,000 Jobs To Lower Costs

HP Inc. Q4 Earnings Summary

HP Inc. Q4 22 Earnings Conference Call At 5:00 PM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

Fresh Ideation Recalls Sandwiches And Other Products

FSIS Warns Against Ready-To-Eat Stuffed Chicken Product

FSIS Warns Against Wegmans Chicken Korma With Basmati Turmeric Rice

Daiso Recalls Certain Prepackaged Snacks

Children's Robes, Pajamas Recalled On Burn Risks

China's Xpeng Launches Two Smart EVs For Europe

Shop Me Ca Recalls Diep Bao Cream For Lead Concerns

IBSA Pharma Recalls TIROSINT-SOL Oral Solution

FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis

FSIS Warns Against RTE Meat Snack Products With Recalled Wafers

Humana Q4 Loss Widens On Charges

Two Rivers Coffee Recalls Peanut Butter Hot Chocolate

Humana Q4 Loss Widens On Charges

Two Rivers Coffee Recalls Peanut Butter Hot Chocolate

Software AG Q4 Organic Operating EBITA Rises; To Become Leaner Organization

Kyndryl In Deal To Manage Stellantis' Core IT Infrastructure

EC Approves Label Expansion Of Roche' Hemlibra To Include People With Moderate Haemophilia A

Canada Goose Drops 14% On Lower Profit, Decreased Outlook

FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis

INOVIO Pharma Announces Positive Results From Phase 1b Clinical Trial Evaluating INO-4201

AstraZeneca, Amgen's Tezspire Pre-filled Pen Receives FDA Approval In US For Asthma

Bristol-Myers Squibb Guides FY23 Adj. EPS In Line; Q4 Results Top Estimates

FirstEnergy To Sell Addl 30% Stake In FirstEnergy Transmission To Brookfield

Gilead Sciences Inc. Q4 Profit Increases, beats estimates

Bristol-Myers Squibb Guides FY23 Adj. EPS In Line; Q4 Results Top Estimates

Alphabet Inc. Bottom Line Declines In Q4, misses estimates

Hologic Inc Q1 Profit Decreases, but beats estimates

Becton, Dickinson Boosts FY23 Outlook - Update

Pinterest To Eliminate About 150 Jobs : Report

Camden Property Trust Q4 Profit Falls

Aptiv Q4 Profit Up, Above Estimates - Update

Timken Guides FY23 In Line With View; Q4 Adj. EPS Tops Estimates

UGI Corp. Q1 Loss Rises

Two Rivers Coffee Recalls Peanut Butter Hot Chocolate

Snap-On Inc. Reveals Increase In Q4 Bottom Line, Beats estimates

Deutsche Bank Q4 Earnings Soar